OSU-03012
Cat. No.:YN420051
产品名称: | OSU-03012 |
CAS No.: | 742112-33-0 |
Chemical Name: | 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide |
Synonyms: | AR-12 |
分子量: | 460.45 |
分子式: | C₂₆H₁₉F₃N₄O |
SMILES: | O=C(CN)NC1=CC=C(C=C1)N2N=C(C=C2C3=CC=C4C5=CC=CC=C5C=CC4=C3)C(F)(F)F |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | OSU-03012 是一种可以通透血脑屏障的PDK-1抑制剂,IC50为 5 μM。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Subbaramaiah, K., and Dannenberg, A.J.Cyclooxygenase 2: A molecular target for cancer prevention and treatmentTrends Pharmacol. Sci.24(2),96-102(2003)
Johnson, A.J., Smith, L.L., Zhu, J., et al.A novel celecoxib derivative, OSU03012, induces cytotoxicity in primary CLL cells and transformed B-cell lymophoma cell line via a caspase- and Bcl-2-independent mechanismBlood105(6),2504-2509(2005)
Zhu, J., Huang, J.W., Tseng, P.H., et al.From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitorsCancer Res.64,4309-4318(2004)
Kucab, J.E., Lee, C., Chen, C.S., et al.Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumorsBreast Cancer Res.7(5),R796-R807(2004)